Skip to content

Singing for Chronic Pain, a New Intervention for the Management of Chronic Pain

Singing for Chronic Pain, a Pilot Study of a New Intervention for the Management of Chronic Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04111861
Enrollment
24
Registered
2019-10-01
Start date
2020-03-03
Completion date
2022-08-18
Last updated
2021-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The aim of the project is to determine the feasibility of delivering a Singing for Chronic Pain (SCP) programme to patients with chronic pain attending a pain clinic. The investigator will also be looking to provide a preliminary estimate of the benefit of SCP on self-efficacy, self -management skills, mindfulness and well-being as measured by standardized outcome measures.

Interventions

OTHERSinging

To investigate whether singing can help people to manage their chronic pain the applicants, working together with people with chronic pain, have developed a singing intervention, Singing for Chronic Pain (SCP). The development of the programme has been supported by Snape Moultings, an international centre for the arts which offered the team a residency to develop the programme (https://snapemaltings.co.uk/music/residencies/). The model takes a holistic approach using voice and singing, movement, sound, mindfulness and breath work to provide opportunities to connect body, voice, breath and mind. This is important given that people often use body dissociation as a way to cope with physical pain

Sponsors

Royal Cornwall Hospitals Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older and have a diagnosis of chronic pain with a duration of 6 months or more.

Exclusion criteria

* Having a mental health and/or physical health diagnosis that might prevent active engagement/participation in group sessions; Severe hearing impairment; Severe/profound cognitive impairment that may limit active engagement/participation in group sessions.

Design outcomes

Primary

MeasureTime frameDescription
Consent rateOne yearMeasure of those offered the programme who consent to take part
Completion rateOne yearMeasure of attendance at sessions

Secondary

MeasureTime frameDescription
Self reported ability to self-manage painOne yearPatient Activation Measure questionnaire
Increased mindfulness Increased mindfulness Increased mindfulnessOne yearFrieburg Mindfulness questionnaire
Self reported well-beingOne yearEdinburgh Warwick Well-being questionnaire
Self reported anxiety depressionOne yearHospital Anxiety and Depression questionnaire.The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression. Anxiety scores and depression scores can range for 0 -21 with a higher score being worse. The separate depression and anxiety scores scores can be combined to give an overall score.
Self reported quality of lifeOne yearEQ5D Quality of Life Questionnaire The EQ-5D questionnaire has two components: health state description and evaluation.Health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The respondents self-rate their level of severity for each dimension using three-level (EQ-5D-3L) or five-level (EQ-5D-5L) scale. In the evaluation part, the respondents evaluate their overall health status using the visual analogue scale (EQ-VAS).he answers given to ED-5D permit to find 243 unique health states or can be converted into EQ-5D index an utility scores anchored at 0 for death and 1 for perfect health. The EQ-5D questionnaire also includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
Self reported self efficacyOne yearPain Self-efficacy questionnaire

Other

MeasureTime frameDescription
Patient Focus GroupOne yearAt week 10, participants will be invited to take part in a 60 minute focus group led by an experienced researcher. The focus groups will explore participants' perception of the programme and its outcomes, reasons for noncompliance, instrument appropriateness and suggestions for programme improvement

Countries

United Kingdom

Contacts

Primary ContactJosephine Erwin
josephine.erwin@nhs.net01872 256439

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026